Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Measured vs PlexusDx

Measured
Graded #58

Higher grade

vs+7.3999999999999915
PlexusDx
Graded #158

Lower grade

The verdict

Measured takes it — 75.1/100 to 67.7/100.

Measured grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Measured is a metabolic-health membership pairing GLP-1 treatment with 1:1 nutrition support and board-certified provider care.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMeasured +12
86
74
Dose & formulationMeasured +13
77
64
Clinical oversightMeasured +13
87
74
Labs & monitoringMeasured +11
63
52
FulfillmentPlexusDx +11
67
78
Contract termsPlexusDx +14
41
55
Measured · left barPlexusDx · right bar

The numbers

MetricMeasuredPlexusDx
WeighScore75.1/10067.7/100
GradeCC
Scorecard rank#58#158
Semaglutide$119/mo (compounded)$149/mo (starting dose, compounded)
Tirzepatide$219/mo (compounded)$249/mo (starting dose, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Measured

Graded #58 · C

Strengths

  • Membership includes 1:1 nutrition support and board-certified provider care
  • Both compounded (from $79/mo microdose, $119 semaglutide, $229 tirzepatide) and brand-name Wegovy/Zepbound
  • Insurance or cash-pay options for brand-name medications
  • Oral option available (Wegovy pill); cancel-anytime membership

Where it loses points

  • The headline $79 'GLP-1 Microdose' is a promotional rate off a $99 list price, is filed by the provider under longevity rather than weight loss, and is not a labelled therapeutic dose of either molecule
  • Branded plans are a $49/mo membership with the medication billed separately at $149 to $449/mo
  • The site never states which billing term its 'from' prices assume, though the terms allow monthly, quarterly, semi-annual and annual
  • No state count is published
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
PlexusDx

Graded #158 · C

Strengths

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Where it loses points

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard